Close Menu

NEW YORK – Abbott today said that its Diagnostics business revenues grew 2 percent year over year in the second quarter, while its total revenues were up 3 percent.

For the three months ended June 30, the Abbott Park, Illinois-based firm reported overall Q2 revenues of $7.98 billion, up from $7.77 billion in Q2 2018, and up 8 percent on an organic basis. The company missed the consensus Wall Street estimate of $8.00 billion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.